Glioma, a type of brain tumor, is known to be associated with dysregulated cell death pathways, making it a prime candidate for investigation of the role of SLC31A1.To this end, we analyzed data from online databases to investigate the relationship between SLC31A1 gene expression and clinical outcomes and the tumor microenvironment in glioma patients. The gene discussed is SLC31A1; the disease is neoplasm.